Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study.
Derijks
Hieronymus J
HJ
Janknegt
Robert
R
Heerdink
Eibert R
ER
De Koning
Fred H P
FH
Krekels
Marielle M
MM
Looij
Bert-Jan
BJ
Egberts
Antoine C G
AC
D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D015283:Citalopram / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy* / Q000523:psychology; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D017374:Paroxetine / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D000928:Antidepressive Agents; D015415:Biomarkers; D015283:Citalopram; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; C517652:hemoglobin A1c protein, human